Skip to main content

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More

Notice: Street Closure

Street Closure: Texas Medical Center Campus road closures, September 29 - October 1, that will impact patients and visitors. Learn More | En Español

Mehmet Fatih Okcu, MD, MPH


Texas Medical Center

Cancer and Hematology
Phone: 832-822-4242
Fax: 832-825-4202


6701 Fannin St., Ste. 1510
Houston, TX 77030

Mehmet Fatih Okcu, MD, MPH

Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine


School Education Degree Year
University of Texas Medical School at Houston Other Master of Public Health 2000
University of Texas MD Anderson Cancer Center Fellowship Pediatric Hematology Oncology 1999
University of Texas Medical School at Houston Residency Pediatrics 1995
University of Texas Medical School at Houston Internship Pediatrics 1993
Istanbul University-Turkey Medical School Doctor of Medicine 1989


Dr. Fatih Okcu's longstanding clinical interest and expertise is in brain tumors and solid tumors. He treats all subtypes of brain tumors, and has a special interest in soft tissue sarcomas, Ewing sarcoma, malignant melanoma and rare pediatric cancers. Dr. Fatih Okcu is a member of the Epidemiology and Population Sciences Program, the Solid Tumor Programs, the Long Term Survivor Program, and the Brain Tumor Program.


Organization Name Role
American Academy of Pediatrics (AAP) Member
American Society of Clinical Oncology (ASCO) Member
American Society of Pediatric Hematology-Oncology (ASPHO) Member
Children’s Oncology Group (COG) Member
Society for Neuro-Oncology (SNO) Member

Research Statement

Dr. Fatih Okcu has ongoing studies include late effects after proton radiation therapy in brain tumor patients, reasons for lack of adherence to follow up care in survivors and relationship between genetic polymorphisms and late permanent treatment effects in childhood cancer survivors.

Research Interests

  • Molecular cancer epidemiology
  • Genetic polymorphisms that modify therapy modalities
  • Adverse events secondary to treatment
  • Neurocognitive impairments in childhood long-term survivors

Awards & Honors

2019    Fellows Excellence in Education Award, Texas Children’s Cancer and Hematology Center
2013     Teaching and Evaluation, Fullbright and Javorski Award, Baylor College of Medicine
2013     Fellows Excellence in Education Award, Texas Children’s Cancer and Hematology Center
2009     Faculty Recognition Award for Excellence in Teaching, Texas Children’s Cancer Center and Hematology Service
2008    International Society of Pediatric NeuroOncology
1997     The Scott Carter Fellowship Award, National Childhood Cancer Foundation

Board Certification

American Board of Pediatrics - Pediatric Hematology-Oncology


English, Turkish

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.